These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25201005)

  • 41. Acquired C1-esterase inhibitor deficiency and positive lupus anticoagulant accompanied by splenic marginal zone B-cell lymphoma.
    Sugisaki K; Itoh K; Tamaru J
    Clin Exp Rheumatol; 2007; 25(4):627-9. PubMed ID: 17888223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease].
    Yasuyama M; Kawauchi K; Otsuka K; Tamura H; Fujibayashi M
    Nihon Ronen Igakkai Zasshi; 2014; 51(6):569-75. PubMed ID: 25749330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
    Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
    Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
    Matutes E; Oscier D; Montalban C; Berger F; Callet-Bauchu E; Dogan A; Felman P; Franco V; Iannitto E; Mollejo M; Papadaki T; Remstein ED; Salar A; Solé F; Stamatopoulos K; Thieblemont C; Traverse-Glehen A; Wotherspoon A; Coiffier B; Piris MA
    Leukemia; 2008 Mar; 22(3):487-95. PubMed ID: 18094718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and biological diversity of splenic marginal zone lymphoma.
    Matutes E
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
    [No Abstract]   [Full Text] [Related]  

  • 48. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
    Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
    Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study.
    Pata G; Bartoli M; Damiani E; Solari S; Anastasia A; Pagani C; Tucci A
    Int J Surg; 2017 May; 41():143-149. PubMed ID: 28366762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Schaefer IM; Marx A; Sauer C; Hohloch K; Ghadimi BM; Trümper L; Ströbel P
    Histopathology; 2013 Mar; 62(4):664-7. PubMed ID: 23379885
    [No Abstract]   [Full Text] [Related]  

  • 52. [Possible contribution of disseminated Mycobacterium shigaense infection to development of splenic marginal zone lymphoma].
    Hatsuse M; Daikoku Y; Taminishi Y; Fuchida SI; Takemura Y; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2018; 59(7):878-883. PubMed ID: 30078797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of splenic marginal zone lymphoma.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Vassilakopoulos TP
    Best Pract Res Clin Haematol; 2017; 30(1-2):139-148. PubMed ID: 28288709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.
    Fabbri A; Gozzetti A; Lazzi S; Lenoci M; D'Amuri A; Leoncini L; Lauria F
    Clin Lymphoma Myeloma; 2006 May; 6(6):496-9. PubMed ID: 16796783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy.
    Debiasi M; Hehnemann M; Garicochea B
    Sao Paulo Med J; 2010 Dec; 128(6):375-7. PubMed ID: 21308163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
    Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
    Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
    J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphoma-associated paraneoplastic angioedema with normal C1-inhibitor activity: does danazol work?
    Gaur S; Cooley J; Aish L; Weinstein R
    Am J Hematol; 2004 Nov; 77(3):296-8. PubMed ID: 15495244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.